Representative before the EPO

Company dna jacobacci and partners spain
no operation time available
2 offices
active in Legal Services

Emilio Alonso Langle has worked on the following 1 EPO patent applications which have been published in the last five years:

EP11382159

Imidazopyrazines derivates as kinase inhibitors

IPC classification:
A61K 31/4985, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Emilio Alonso Langle, Jacobacci & Partners Spain
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature